Manufacturer
Novo Nordisk Pharmaceutical Industries
Pharmaceutical manufacturer based in Denmark
Denmark
- Products listed
- 23
- Molecules
- 4
- Therapy areas
- 1
Novo Nordisk Pharmaceutical Industries is a pharmaceutical manufacturer based in Denmark. MedsAcross lists 23 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Denmark
- Indian manufacturer
- No
- Also listed as
- Novo Nordisk Pharmaceutical Industries, LP
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Novo Nordisk Pharmaceutical Industries products through licensed channels, with the documents your regulator needs.
Diabetes
23 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Awiqli 700 units/mL injectionSubcutaneous | Insulin icodec | US FDA | Available on request |
| NovoLog Mix 70/30 100 IU/mL injectable suspensionSubcutaneous Cold chain | Insulin aspart | US FDA | Available on request |
| Ozempic 1.5 mg tabletOral | Semaglutide | US FDA | Available on request |
| Ozempic 2.04 mg/3 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Ozempic 4 mg tabletOral | Semaglutide | US FDA | Available on request |
| Ozempic 4.02 mg/3 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Ozempic 8.04 mg/3 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Ozempic 9 mg tabletOral | Semaglutide | US FDA | Available on request |
| Rybelsus 14 mg tabletOral | Semaglutide | US FDA | Available on request |
| Rybelsus 3 mg tabletOral | Semaglutide | US FDA | Available on request |
| Rybelsus 7 mg tabletOral | Semaglutide | US FDA | Available on request |
| Saxenda 18 mg/3 mL injectionSubcutaneous Cold chain | Liraglutide | US FDA | Available on request |
| Wegovy 0.25 mg/0.5 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 0.5 mg/0.5 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 1 mg/0.5 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 1.13333 mg/0.5 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 1.5 mg tabletOral | Semaglutide | US FDA | Available on request |
| Wegovy 2.4 mg/0.75 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 25 mg tabletOral | Semaglutide | US FDA | Available on request |
| Wegovy 3.2 mg/mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 4 mg tabletOral | Semaglutide | US FDA | Available on request |
| Wegovy 7.2 mg/0.75 mL injectionSubcutaneous | Semaglutide | US FDA | Available on request |
| Wegovy 9 mg tabletOral | Semaglutide | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Novo Nordisk Pharmaceutical Industries
Send a request for any of these products. We confirm the licensed source, documents and lead time.